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Abstract
Background: As per the vaccine management policy of the Government of India all vaccine vials opened for an 
immunization session were discarded at the end of that session, irrespective of the type of vaccine or the number of 
doses remaining in the vial prior to 2013. Subsequently, open vial policy (OVP) was introduced in 2013 and should 
reduce both vaccine wastage as well as governmental healthcare costs for immunization. This study evaluates the 
vaccine wastage after introduction of the OVP and its comparison with the previous study of vaccine wastage 
in Surat city before implementation of OVP. It needs to mention that the vaccine policy for this period under 
comparison was uniform except for the OVP.
Methods: Information regarding vaccine doses consumed and children vaccinated during immunization sessions 
of 24 urban health centers (UHCs) of Surat city were retrieved for the period of January 1st, 2014 to March 31st, 
2014. The data were analyzed to estimate vaccine wastage rate (WR) and vaccine wastage factor (WF). In order to 
assess the impact of OVP, vaccine WR of this study was compared with that of previous study conducted in Surat 
city during January 1st, 2012 to March 31st, 2012.
Results: The vaccine WR for oral polio vaccine (OPV) has decreased from 25% to 13.62%, while the WRs for 
DPT, hepatitis B virus (HBV) and the pentavalent vaccine combinedly have decreased from 17.94% to 8.05%. 
Thus, by implementation of OVP, an estimated 747 727 doses of OPV and 343 725 doses of diphtheria, pertussis 
and tetanus toxoid vaccine (DPT), HBV and the pentavalent vaccines combinedly have been saved in Surat city 
of India in a year.
Conclusion: The implementation of the OVP in Surat city has led to a significant lowering in the vaccine wastage, 
leading to savings due to lower vaccine requirements. 
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Implications for policy makers
• Wastage rates (WRs) for oral polio vaccine (OPV) and injectable vaccines (DPT, hepatitis B [HBV] and pentavalent) have reduced by 50% 
after introducing open vial policy (OVP) in Surat city. 
• We estimate that this reduction in vaccine wastage has led to an estimated saving of US$0.7 million in the current health expenditure for 
immunization in Surat city. 
• The vaccine WRs calculated in this study could prove useful for program managers in forecasting vaccine requirements elsewhere.
Implications for public
Vaccine supply for immunization is an essential expenditure to be borne by governments as health is an essential good for the development of a 
country. Financial constraints and unnecessary vaccine wastage in developing countries as India may translate into a numerically fewer children 
being vaccinated with the same resources. Therefore, it is prudent to minimize vaccine wastage and render additional doses to be made available 
for vaccination. This increases the cost-effectiveness of our immunization program, leads to an increased immunization coverage and increases 
the number of children protected from vaccine-preventable diseases. Thus, in this context open vial policy (OVP) would be helpful to decrease the 
economic costs and the burden of un-immunization and partial immunization of children in our society.
Key Messages 
Introduction
Universal Immunization Program (UIP) was launched in 
1985 in India with intent to immunize all eligible children by 
1990. Our program guidelines dictated that a fresh vaccine 
vial was to be opened before the immunization session even if 
there was only one child requiring vaccination.1 The previous 
immunization policy had also stated that all vaccine vials 
opened for an immunization session had to be discarded at 
the end of that session, irrespective of the type of vaccine or 
the number of residual doses in the vial.2
Later as per the revised open vial policy (OVP), multi-dose 
vials of oral polio vaccine (OPV), Diphtheria, pertussis and 
tetanus toxoid vaccine (DPT), tetanus toxoid (TT), diphtheria 
and tetanus toxoid (DT), pentavalent, hepatitis B virus (HBV) 
and liquid formulations of Haemophilus influenzae type 
b (Hib) vaccines from which one or more doses have been 
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removed during an immunization session could be used in 
successive sessions for a maximum of 4 weeks, provided that 
all of the World Health Organization (WHO) requirements 
for effectiveness and temperature stability were met.3
The WHO reports that over 50% of vaccine are wasted 
globally.4 Over-ordering of vaccines is the leading problem in 
the distribution chain, and causes the majority of wastage.5 
Thus vaccine wastage is an important factor in forecasting 
vaccine requirements and while placing vaccine orders.
India being a developing economy needs to reduce avoidable 
vaccine wastage and wasteful budgetary requirements. 
Therefore, the introduction of new vaccine management 
policy (OVP, 2013) seems a prudent economic choice given 
reduced vaccine wastage and increased cost-benefit ratio of 
immunization. This study was conducted to compare vaccine 
wastage before and after introducing the OVP by the Surat 
Municipal Corporation (SMC) for Surat city of India.
We are well-aware that our vaccine supply is limited owing 
to budgetary constraints. Therefore, any vaccine wastage 
translates into fewer vaccine doses actually available 
to children and also a higher cost of vaccination.6 Any 
minimization of this cost would be a welcome step in fiscal 
planning. It needs mention that the Government of Gujarat 
introduced the pentavalent vaccine in UIP in January 2013 
and OVP for multi-dose vials was made available from April 
2013 in Gujarat.7
This article attempts to calculate the vaccine WRs after 
introducing OVP in SMC area and the impact of OVP on 
vaccine wastage by comparing it with the previous study in 
Surat city before implementation of OVP.
Methods
The data from urban heath centers (UHCs) of SMC has 
been analyzed for the vaccine wastage for various vaccines. 
The information regarding vaccine doses consumed during 
immunization sessions and number of vaccinated children 
were retrieved from the immunization registers for the period 
of January 1st, 2014 to March 31st, 2014 (ie, after introduction 
of OVP) maintained by the public health nurses.
We have included 24 out of 40 UHCs, covering 1964 
immunization sessions, of SMC as only these centers could 
provide complete immunization data. Six centers where daily 
in and out of vaccine vials as well as vaccination details of 
each session were not maintained properly were excluded and 
remaining ten centers had pleaded their temporary inability to 
provide a complete data due to their participation in ongoing 
public health programs.
The number of doses wasted for a particular vaccine was 
calculated by subtracting number of vaccinated children 
from the total vaccine doses consumed in a session. Here 
‘vaccine doses consumed in a session’ imply the number of 
doses issued for the session and not returned back. We have 
included only the number of usable vials for our calculations. 
We were unable to find any unusable vaccine vials at various 
UHCs during our supervision visits as revealed by vaccine 
vial monitors. Further the vaccine vials discarded because 
lesser number of children available at vaccination session 
sites were in usable condition. Proportion of wasted doses 
from total consumed doses was considered as vaccine WR.2 
Vaccine wastage factor (WF) was calculated by using the 
formula [100/(100-Vaccine WR)].2 
The vaccine WR and vaccine WF of open multi-dose vials 
of all liquid vaccines were compared with that of previous 
study conducted by our department ie, Mehta et al8 in Surat 
city during January 1st, 2012 to March 31st, 2012 (ie, before 
introduction of OVP). In 2012 study,8 out of 36 health centers 
24 had been included covering 2399 immunization sessions. 
During this study also 24 out of 40 centers were included 
covering 1964 immunization sessions. The method used for 
estimating WR and WF in both studies remain the same.
As the pentavalent vaccine was not introduced at the time 
of previous study, the vaccine WR and vaccine WF for DPT, 
pentavalent, and HBV has been clubbed together in this study 
and compared with the combined vaccine WR and vaccine 
WF of DPT and HBV of the previous study. The pentavalent 
vaccine has replaced DPT and HBV and that is why they are 
deemed comparable and also all of these vaccines have similar 
administration techniques. However, the children who had 
received partial doses of DPT and HBV had continued with 
the past regimens.
Results
In 24 UHCs, total 1964 immunization sessions had been 
conducted during the study period. Six vaccines (bacille 
Calmette-Guerin vaccine [BCG], OPV, DPT, pentavalent, 
HBV and measles) were given to children. The information 
regarding the number of vaccine doses consumed for 
vaccination, children vaccinated, vaccine WR, and vaccine 
WF are depicted in Table 1. To measure the impact of OVP on 
vaccine wastage, only data regarding open multi-dose vials of 
liquid vaccines (OPV, DPT, pentavalent, and HBV) have been 
used and compared with the data of the previous study.
In the first quarter of 2014, 48 501 doses of OPV were actually 
ingested by the children whereas 56 150 doses of the vaccine 
were used. This translates into vaccine WR of 13.62% and 
vaccine WF of 1.16% for OPV. Earlier, in first quarter of 2012, 
vaccine WR and vaccine WF for OPV was 25% and 1.33%, 
respectively. This shows a significant decline in vaccine WR 
Table 1. Vaccine WR and Vaccine WF for Different Liquid Vaccines
Vaccine (Reference Period) Doses Consumeda Actual Doses Received by Childrenb Vaccine WR Vaccine WF 
P Value (Using Z Test 
of Proportion)
OPV (January-March 2012) 42 290 31 732 25.00% 1.33
<0.001
OPV (January-March 2014) 56 150 48 501 13.62% 1.16
DPT and HBV (January-March 2012) 91 249 74 883 17.94% 1.22
<0.001
DPT, HBV, and pentavalent (January-March 2014) 51 858 47 686 08.05% 1.09
Abbreviations: OPV, oral polio vaccine; HBV, hepatitis B virus; WR, wastage rate; WF, wastage factor; DPT, diphtheria, pertusis, and tetanus toxoid vaccine.
a These were the doses calculated by subtraction of vaccine doses issued before the vaccination session and doses received at the end of vaccination session.
b These were the doses actually received by the children based on the actual doses administered. These children have individual registration and addresses 
listed for each entry and are cross verifiable.
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and vaccine WF for OPV after implementation of OVP 
(P < .001). It has been mentioned earlier that these vaccine 
doses wasted were usable as per the vaccine vial monitor.
In first quarter of 2012, DPT and HBV vaccines were given 
separately. All children receiving first, second or third dose of 
DPT were provided with HBV vaccine while DPT booster was 
given without HBV (6, 10, and 14-week schedule followed for 
HBV). Combining both the vaccine, total 74 883 doses were 
injected to children in the quarter and for that 91 249 doses of 
vaccines were actually used. 
In January 2013, pentavalent vaccine was introduced replacing 
both DPT and HBV in newly registered children. Those 
children who had already received one or more doses of DPT 
were continued on the same vaccine till second booster. In 
first quarter of 2014, 32 092 doses of pentavalent, 14 702 doses 
of DPT, and 892 doses of HBV were actually injected to the 
children. Thus, a total of 47 686 injections were provided to 
the children and for which 51 858 doses were used. This gives 
a vaccine WR of 8.05% and vaccine WF of 1.09%. 
Earlier, in first quarter of 2012, vaccine WR and vaccine WF 
for DPT+HBV was 17.94% and 1.22%, respectively. This data 
again shows a significant decline in vaccine WR and vaccine 
WF for DPT, HBV, and pentavalent after implementation of 
OVP (P < .001). As mentioned earlier the techniques for the 
administration of DPT, HBV, and pentavalent vaccines are 
similar and the administrative guidelines have not changed 
except for introduction of the OVP.
There is a decline in number of injections provided to the 
children in 2014 as compared to 2012 as majority of the 
children are now receiving a single injection of pentavalent 
vaccine, instead of double injections of DPT and HBV vaccine 
in the earlier vaccination schedule.
Table 2 shows estimated used doses of OPV, DPT, HBV, and 
pentavalent vaccine based on the WF of year 2012 and 2014 
ie, before and after implementation of OVP. This estimation 
indicates that after implementation of OVP, an estimated 
747 727 doses of OPV and 343 725 doses of DPT, HBV, 
and pentavalent have been saved in Surat city in the year 
2014. It needs mention that the vaccination techniques and 
administrative guidelines remain the same among all of the 
UHCs surveyed, except for the introduction of the pentavalent 
vaccine and the OVP.
Discussion
According to the WHO, the acceptable vaccine WR for liquid 
vaccines is 25%.9 The Ministry of Health and Family Welfare, 
Government of India has also recommended that vaccine WR 
of all vaccines should not be higher than 25% (vaccine WF of 
1.33%).10 The vaccine WR for OPV in the present study (after 
implementation of OVP) is 13.62% which is lower than the 
recommended limits,9,10 while in the previous study (before 
implementation of OVP) the vaccine WR was 25% which was 
just equal to the recommended wastage limits.8
Most freeze-dried (lyophilized vaccines) do not contain 
preservatives and consequently must not be kept for more 
than the manufacturers recommended limit and never longer 
than 6 hours after they are reconstituted.11 Liquid injectable 
vaccines such as DPT, TT, DT, pentavalent, HBV, and liquid 
formulations of Hib vaccines contain preservatives that 
prevent growth of bacterial contamination.11 Thus, the OVP 
is applicable to liquid injectable vaccine and OPV only.
The vaccine WR for DPT, HBV, and pentavalent is 
combinedly 8.05% in the present study which is much lower 
than the recommended limits,9,10 while in the previous study,8 
the vaccine WR for DPT and HBV was combinedly 17.94% 
which was almost double as compared to the present study. 
The vaccine WR for all liquid injectable vaccines affected by 
OVP are also lower in this study as compared with the vaccine 
WR of other studies.12-14
Among all the reasons of vaccine wastage, “residual vaccine 
left in the vial” was the most frequently reported reason for 
wastage of vaccines reported by earlier authors.15,16 OVP 
permits the use of open multi-dose vials of vaccines for 
extended periods of time (up to 28 days), previously which 
had to be discarded at the end of vaccination session. The use 
of this residual vaccine is the reason for the improvement in 
vaccine WR.
According to Mehta et al8 vaccine wastage was also found to 
be more where sessions are smaller in size. In smaller sessions, 
more vaccine doses are left over at the end of the sessions which 
used to be discarded earlier. Now, OVP permits utilization of 
these left over doses in subsequent sessions which leads to an 
improvement in vaccine WR and at the same time ensures the 
vaccine safety.
Based on the economic computation model by Lee et al,2 OVP 
Table 2. Estimation of Total Saved Doses in Surat City in a Year After Introduction of OVP
Vaccine OPV DPT, HBV, and Pentavalent
Vaccine WF before implementation of OVPa (See reference 6) 1.33 1.22
Vaccine WF after implementation of OVPb 1.16 1.09
Estimated vaccine doses consumed in SMC during 2014c 6 785 840 3 516 040
Projected vaccine doses wasted in 2014 if OVP was not implementedd 1 683 705 634 040
Estimated vaccine doses wasted in 2014 after implementation of OVPe 935 978 290 315
Estimated vaccine doses saved due to implementation of OVP 747 727 343 725
Abbreviations: OPV, oral polio vaccine; OVP, open vial policy; HBV, hepatitis B virus; SMC, Surat Municipal Corporation; WR, wastage rate; WF, wastage factor. 
a Vaccine WF according to the study done by Mehta et al8 in Surat city during January-March 2012.
b Vaccine WF calculated in this study from the data of January-March 2014. Vaccine WF was calculated by using the formula Vaccine WF = [100/(100-Vaccine 
WR)].
c Estimated vaccine doses consumed was calculated from data provided by immunization cell of SMC which include vaccine provided through 40 urban heath 
centers (UHCs)  across the city. Vaccine consumption of April–September 2014 was doubled to estimate the yearly consumption of vaccine doses for all 40 
UHCs of SMC.
d Total vaccine doses wasted in absence of OVP was calculated by taking the vaccine WF of year 2012.8 Vaccine doses wasted was calculated by the formula 
‘Total doses wasted’ = Total consumption x [1-(1/vaccine WF)].
e Total vaccine doses wasted after implementation of OVP was calculated by taking the vaccine WF of year 2014. Wasted doses were calculated by formula ‘Total 
doses wasted’ = Total consumption x [1-(1/vaccine WF)].
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has the potential to reduce vaccine WR up to 30%, without 
affecting the immunization coverage. In present study, 
vaccine WR was reduced 45.52% and 55.13% for OPV and 
injectable (DPT, HBV, and pentavalent) vaccines, respectively, 
and at par with the prediction of the computation model.
The above-mentioned modeling also predicts annual saving 
of $40 million worldwide.3 In the present study, 747  727 
doses of OPV and 343 725 doses of injectable (DPT, HBV, 
and pentavalent) vaccine could be saved. Taking approximate 
cost of OPV11 and pentavalent vaccine18 INR 3.6 and INR 
120.0 per dose, respectively, an estimated annual cost saving 
is INR 43.94 million ($0.70 million taking conversion rate 
62.46 dated March 26th, 2015). For all doses of DPT, HBV, 
and pentavalent saved, the unit cost of pentavalent has been 
considered because most of the vaccine doses were of this 
type.
Conclusion
Implementation of OVP has significantly reduced vaccine 
wastage of OPV and liquid injectable vaccines (DPT, HBV, and 
pentavalent) for Surat city. The WRs of OPV and injectable 
vaccines reduce by 50% after introduction of this new policy. 
The reduction in vaccine wastage by application of the OVP 
has helped Surat city by an estimated savings of $0.7 million in 
our current vaccination drive. The vaccine WRs as calculated 
in this study could prove useful for program managers to 
forecasts their vaccine requirements, provided other factors 
affecting open vial’s usability and administration systems 
remain unchanged.
Limitations
In this study, we could not cover all health centers owing 
to reasons as ascribed. This being a non-systemic exclusion 
should not affect the results of the study. In the study, all 
estimations have been based on the information obtained for 
a period of three months and on this basis yearly forecasts 
have been made. It needs mention that these three months 
were common for both the studies for the pre and post OVP. 
This study covers a large numbers of vaccination sessions so 
exclusions of the remaining sessions are anticipated to have 
very little effects on the outcome. Changes in vaccines efficacy 
after introduction of OVP need to be evaluated separately as 
this variable has not been included in this study.
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